| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1298 | 2018 |
| AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Pharmacopsychiatry 21 (06), 195-235, 2011 | 1110 | 2011 |
| Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence CB Eap, T Buclin, P Baumann Clinical pharmacokinetics 41, 1153-1193, 2002 | 766 | 2002 |
| The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry P Baumann, C Hiemke, S Ulrich, G Eckermann, I Gaertner, M Gerlach, ... Pharmacopsychiatry 37 (06), 243-265, 2004 | 599 | 2004 |
| Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study G Bondolfi, H Dufour, M Patris, JP May, U Billeter, CB Eap, P Baumann American Journal of Psychiatry 155 (4), 499-504, 1998 | 408 | 1998 |
| Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors P Baumann Clinical Pharmacokinetics 31, 444-469, 1996 | 325 | 1996 |
| Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment S Crettol, JJ Déglon, J Besson, M Croquette‐Krokkar, I Gothuey, ... Clinical Pharmacology & Therapeutics 78 (6), 593-604, 2005 | 281 | 2005 |
| A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and … P Baumann, R Nil, A Souche, S Montaldi, D Baettig, S Lambert, ... Journal of clinical psychopharmacology 16 (4), 307-314, 1996 | 235 | 1996 |
| Advantages and disadvantages of combination treatment with antipsychotics: ECNP Consensus Meeting, March 2008, Nice G Goodwin, W Fleischhacker, C Arango, P Baumann, M Davidson, ... European Neuropsychopharmacology 19 (7), 520-532, 2009 | 194 | 2009 |
| Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine DF Zullino, D Delessert, CB Eap, M Preisig, P Baumann International clinical psychopharmacology 17 (3), 141-143, 2002 | 190 | 2002 |
| ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine EJ Sirot, B Knezevic, GP Morena, S Harenberg, B Oneda, S Crettol, ... Journal of clinical psychopharmacology 29 (4), 319-326, 2009 | 179 | 2009 |
| Nonresponse to Clozapine and Ultrarapid CYP1A2 Activity: Clinical Data and Analysis of: CYP1A2: Gene CB Eap, S Bender, EJ Sirot, G Cucchia, M Jonzier-Perey, P Baumann, ... Journal of clinical psychopharmacology 24 (2), 214-219, 2004 | 174 | 2004 |
| Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence N Sartorius, TC Baghai, DS Baldwin, B Barrett, U Brand, W Fleischhacker, ... International Journal of Neuropsychopharmacology 10 (Supplement_1), S1-S207, 2007 | 172 | 2007 |
| Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes B Rochat, M Amey, M Gillet, UA Meyer, P Baumann Pharmacogenetics and Genomics 7 (1), 1-10, 1997 | 152 | 1997 |
| Binding of d‐methadone, 1‐methadone, and dl‐methadone to proteins in plasma of healthy volunteers: Role of the variants of α1‐acid glycoprotein CB Eap, C Cuendet, P Baumann Clinical Pharmacology & Therapeutics 47 (3), 338-346, 1990 | 152 | 1990 |
| Cytochrome P450 2D6 genotype and methadone steady-state concentrations CB Eap, F Broly, A Mino, R Hammig, JJ Déglon, C Uehlinger, D Meili, ... Journal of clinical psychopharmacology 21 (2), 229-234, 2001 | 149 | 2001 |
| Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment CB Eap, M Bourquin, JL Martin, J Spagnoli, S Livoti, K Powell, ... Drug and alcohol dependence 61 (1), 47-54, 2000 | 148 | 2000 |
| Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography B Rochat, M Amey, P Baumann Therapeutic drug monitoring 17 (3), 273-279, 1995 | 148 | 1995 |
| Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography—mass spectrometry CB Eap, G Bouchoux, M Amey, N Cochard, L Savary, P Baumann Journal of Chromatographic Science 36 (7), 365-371, 1998 | 142 | 1998 |
| Enantiomers’ potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram P Baumann, DF Zullino, CB Eap European neuropsychopharmacology 12 (5), 433-444, 2002 | 141 | 2002 |
Christoph HiemkeUniversity Medical Center Mainz在 uni-mainz.de 的电子邮件经过验证
